Clinical Trial Update: FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FLOX chemotherapy (5-FU, leucovorin, oxaliplatin) plus cetuximab in patients with metastatic colorectal cancer and wild-type K…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• ERBITUX (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Per Pfeiffer | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED